Introduction
p73 is highly similar to p53, especially in the central sequence-speci®c DNA binding domain, the amino terminal activation domain, and the carboxyl terminal tetramerization domain (Chen, 1999; Kaelin, 1999b; Kaghad et al., 1997; Yang and McKeon, 2000) . The p73 gene is expressed as at least six alternatively spliced forms, that is, p73a, p73b, p73g, p73d, p73e, and p73z (De Laurenzi et al., 1998; Kaghad et al., 1997; Laurenzi et al., 1999; Zaika et al., 1999) . Like p53, p73 can induce cell cycle arrest and apoptosis when overexpressed in cells (Jost et al., 1997; Kaghad et al., 1997; Zhu et al., 1998a) . As a sequence-speci®c transcription factor, p73 can recognize several p53 response elements both in vitro and in vivo (Jost et al., 1997; Kaghad et al., 1997; Zhu et al., 1998a) . Loss of p73 transcriptional activity abrogates its ability to induce cell cycle arrest and apoptosis (Jost et al., 1997; Kaghad et al., 1997; Zhu et al., 1998a) . Despite these similarities to p53, p73 dierentially regulates some p53 target genes (Di Como et al., 1999; Marin et al., 1998; Yu et al., 1999; Zhu et al., 1998a) . For example, p21, a cyclin-dependent kinase inhibitor that is primarily responsible for p53-dependent G 1 arrest (Agarwal et al., 1998; Ko and Prives, 1996) , is regulated by p73, but the induction by p73 is several fold lower than by p53. Interestingly, 14-3-3s, which may mediate p53-dependent G 2 -M arrest (Hermeking et al., 1997) , is induced several fold higher by p73 than by p53. These results suggest that the signaling pathways for p53 and p73 in inducing cell cycle arrest and apoptosis are similar but also have important dierences.
The ability of p53 to induce cell cycle arrest and apoptosis can be activated by both intracellular and environmental stresses, e.g., DNA damage agents and hypoxia, in cells that carry an endogenous wild-type p53 gene (Giaccia and Kastan, 1998; Ko and Prives, 1996) . Some of the agents that can activate the p53 pathway are currently used for cancer chemotherapy Weinstein et al., 1997) . In fact, the ecacy of cancer chemotherapy by some therapeutic agents is dependent upon their ability to activate the p53 pathway Weinstein et al., 1997) . Therefore, tumor cells that lack a functional p53 are more resistant to chemotherapeutic agents than cells that contain a functional p53, but can be sensitized when reconstituted with wild-type p53 (Chen et al., 1996; Gallardo et al., 1996; Mukhopadhyay and Roth, 1997; Wang et al., 1998) .
Since p53, but not p73, is frequently mutated in human cancers (Chen, 1999; Ko and Prives, 1996; Levine, 1997) , it is anticipated that p73 may be used to sensitize p53 de®cient tumor cells to cancer therapeutic agents. In this study, we found that p73 cooperates with DNA damage to induce apoptosis in MCF7 breast adenocarcinoma cells that carry an endogenous wild-type p53 gene. In addition, we found that activation of the p53 pathway is necessary for the cooperative induction of apoptosis and cellular target genes by p73 and DNA damage. This result should be taken into consideration when p73 is used as a cancer therapeutic agent.
Results
p53 can sensitize many types of cancer cells, for example, hematopoietic and lymphoid cells, to apoptosis by DNA damaging agents (Lowe et al., 1994; O'Connor et al., 1997) . However, MCF7 cells are less prone to the p53-dependent DNA damage-induced apoptosis. To examine whether p73 can sensitize MCF7 cells to apoptosis by DNA damaging agents, we generated several groups of cell lines that: (i) inducibly express p73a, p73b, or p73a292; (ii) stably express the human papillomavirus (HPV) E6 oncogene and inducibly express p73; and (iii) inducibly express p53. Since the HPV E6 oncogene facilitates the ubiquitin-mediated degradation of p53, the MCF7 cells that express E6 oncogene (MCF7E6) become p53-nulllike. By tagging p73 and p53 with an HA epitope, the relative amount of the exogenous p73 and p53 proteins can be quanti®ed by Western blot analysis with rabbit anti-HA polyclonal antibody. After normalization to the level of actin, we found that comparable levels of HA-p73 and HA-p53 were expressed in MCF7-HAp73a-2, MCF7E6-HA-p73a-45, and MCF7-HA-p53-7 cells when induced (Figure 1 ). We also used several commercial anti-p73 antibodies to detect the endogenous p73 protein in MCF7 cells. We were unable to detect it. This is probably due to the quality of the antibodies and/or the level of the p73 protein expressed in MCF7 cells.
To determine whether these MCF7 derivative cells still contain a functional p53 pathway and whether exogenous HA-p73 and HA-p53 are functonal, we analysed the expression levels of endogenous p53 and p21 following induction of exogenous HA-p73 or HAp53, DNA damage, or both. We found that when treated with camptothecin, p53 was activated, leading to induction of p21 in MCF7 cells (Figure 2a ,c, p53 and p21 panels, compare lanes 1 and 2). In contrast, p53 was not stabilized in MCF7E6 cells when treated with camptothecin, but p21 was slightly induced, presumably in a p53-independent manner (Figure 2b , p53 and p21 panels, compare lanes 1 and 2). When induced by withdrawal of tetracycline, HA-p73a was expressed in both MCF7 and MCF7E6 cells ( Figure  2a We would like to emphasize here that the level of the inducible HA-p53 in MCF7 cells (Figure 2c ) is lower than that of endogenous p53 stabilized by DNA damage (compare lanes 2 and 4) and can be further stabilized by DNA damage (compare lanes 3 and 4). Therefore, the eects of exogenous HA-p53 and possibly HA-p73 on cell proliferation and cell death are physiologically relevant.
Next, we determined whether exogenous HA-p73 and HA-p53 can sensitize MCF7 and MCF7E6 cells to apoptosis by DNA damage agents. We found that in the absence of either DNA damage or induction of HA-p73a, MCF7 and MCF7E6 cells grew normally ( Figure 3a ,e,i). When induced to express exogenous HA-p73a or HA-p53 for 3 days, both MCF7 and MCF7E6 cell proliferation were inhibited ( Figure 3 , Figure 1 Comparable levels of the HA-tagged p73 and p53 are expressed in MCF7 cell lines that inducibly express p73 or p53, and in an MCF7E6 cell line that stably expresses HPV E6 oncogene and inducibly expresses p73. Cells were induced to express p73 or p53 for 24 h, and the levels of p73, p53, and actin proteins were determined by Western blot analysis. Polyclonal anti-HA antibody was used to detect the HA-tagged p73 and p53, and anti-actin polyclonal antibody was used to detect actin compare b with a; f with e; and j with i). When treated with 300 nM camptothecin to induce endogenous p53 but without inducing exogenous HA-p73a or HA-p53, MCF7 cells failed to multiply, but enlarged and attened ( Figure 3 , compare c and a; and k with i). In contrast, MCF7E6 continued to multiply albeit at a slightly slower rate than that of untreated cells ( Figure  3 , compare g and e). In addition, the treated MCF7E6 cells were not signi®cantly enlarged and¯attened ( Figure 3 , compare g with c and k). These results are consistent with previous observations that the p53 pathway is necessary for inhibiting cell proliferation following DNA damage Weinstein et al., 1997) . When cells were induced to express HA-p73a and treated with camptothecin to induce endogenous p53, MCF7 cells either became round or detached from the culture plate and shrank to form apoptotic bodies (Figure 3d ). In contrast, DNA damage was incapable of cooperating with p73a in MCF7E6 cells to induce cell death, but cell proliferation was inhibited by HA-p73 (Figure 3h ). In addition, we found that exogenous HA-p53 was incapable of cooperating with DNA damage to induce apoptosis in MCF7 cells (Figure 3 ). Similar results were obtained when these cells were treated with another therapeutic DNA damaging agent doxorubicin. We also tested MCF7 cells that inducibly express p73b or p73a mutant (p73a292). p73a292 is inert in transcriptional activity and defective in inducing cell cycle arrest and apoptosis (Jost et al., 1997; Kaghad et al., 1997; Zhu et al., 1998a) . When MCF7 cells were induced to express p73b or p73a292, DNA damage cooperated with p73b, but not mutant p73a292, to induce apoptosis. It should be noted that p73a, p73b, and p53 alone can induce a strong apoptotic response in several MCF7 cell lines when a higher level of p73 or p53 is expressed (Zhu et al., 2000 ; data not shown). In addition, the p73-mediated apoptosis can be further enhanced by DNA damage (data not shown).
To quantify the extent of cell death to which exogenous HA-p73 or HA-p53 and DNA damage cooperate to induce in MCF7 cells, trypan blue dye exclusion assay was performed. We measured the percentage of dead cells 3 days after induction of HA-p73a or HA-p53, treated with camptothecin, or both in three separate experiments. In general, approximately 10% of control cells was stained positive (Figure 4a ). This is probably due to trypsinization that was used to remove cells from culture plates. We found that the percentage of dead cells was slightly increased by treatment with camptothecin. While cell proliferation was inhibited by exogenous p73a and p53 in MCF7 cells (Figure 3b,f,j) , no signi®cant increase in cell death was detected (Figure 4a ). However, p73, but not p53, cooperated to induce cell death for up to 40% of total cells in MCF7, but not MCF7E6, cells. The increase is nearly fourfold higher than that in untreated cells (Figure 4a ).
To examine this further, we performed caspase activity assay. Since MCF7 cells harbor a dysfunctional caspase 3 gene (Nagata, 2000) , we determined the activity of caspases 2 and 6. We found that when both treated with camptothecin and induced to express exogenous p73a, the activity of caspase 2 in MCF7 (7) or induced (+) by withdrawal of tetracycline from culture media to express p73 or p53. Both uninduced and induced cells were mock-treated (7) or treated (+) with 300 nM camptothecin (CPT) for 24 h. The levels of p73, p53, p21, and actin proteins were determined by Western blot analysis with anti-p73 monoclonal antibody Ab-1, anti-p53 monoclonal antibody PAb240, anti-p21 monoclonal antibody Ab-1, and anti-actin polyclonal antibody. The fold of induction was shown below each blot cells was increased to a substantially higher level than that in cells treated with camptothecin or induced to express p73a individually (Figure 4b ). We also found that the activity of caspase 6 was similarly activated (data not shown). These results are consistent with the data obtained by the Trypan blue dye exclusion assay (Figure 4a ).
Since the transcriptional activity of p73 is necessary for the enhanced induction of cell death in MCF7 cells treated with the DNA damaging agent camptothecin, it suggests that one or more cellular genes may be responsible for such cooperation. Indeed, p21 was induced cooperatively by exogenous p73 and DNA damage in MCF7 cells (Figure 2a) . To further con®rm this, Northern blot analysis was performed. We found that in MCF7 cells, p21 was induced by DNA damage (Figure 5a ,c, p21 panel), exogenous p73a (Figure 5a,  p21 panel) , or exogenous p53 (Figure 5c, p21 panel) . Figure 3 p73, but not p53, can sensitize MCF7, but not MCF7E6, cells to apoptosis by the DNA damaging agent camptothecin. MCF7 cells that inducibly express p73 were used in (a ± d); MCF7E6 cells that stably express the HPV E6 oncogene and inducibly express p73 were used in (e ± h); and MCF7 cells that inducibly express p53 were used in (i ± l). These cells were mock-treated (a,e,i), induced to express p73 or p53 (b,f,j), treated with 300 nM camptothecin (c,g,k), and both treated with camptothecin and induced to express p73 or p53 (d,h,l) . Magni®cation is 2506for all panels Oncogene Functional interaction between p53 and p73 J Zhu et al When MCF7 cells were treated with camptothecin and induced to express exogenous p73a or p53, p21 was further induced (Figure 5a,c, p21 panel) . In contrast, in MCF7E6 cells, p21 was only slightly induced by DNA damage (*2.2-folds), presumably in a p53-independent manner (Figure 5b, p21 panel) . Since the cell proliferation was not signi®cantly repressed in MCF7E6 cells following DNA damage (Figure 3g ), it appears that this level of p21 induced by DNA damage in MCF7E6 cells is not sucient to arrest cells. However, in MCF7E6 cells, p21 was signi®cantly induced by p73a (Figure 5b, compare lanes 1 and 4) . In addition, p21 was further induced when both treated with camptothecin and induced to express p73a ( Figure  5b, p21 panel) . This is probably due to an increased level of p73 stabilized by DNA damage (Figure 2b, p73  panel) . Nevertheless, the fold of induction of p21 is still lower in MCF7E6 cells than that in MCF7 cells ( Figure 5, p21 panel, compare b with a) . These results are consistent with the data obtained by Western blot analysis (Figure 2 ), suggesting that up-regulation of p21 may be responsible for growth suppression by p73, p53 and DNA damage ( Figure 3) .
Next, we examined the expression of BAX, a proapoptotic p53 target gene. We found that BAX was not, or only slightly, induced by DNA damage, p73, and p53 individually ( Figure 5 , BAX panel). However, when treated with camptothecin and induced to express p73, a higher level of BAX was induced in MCF7 cells than in MCF7E6 cells (Figure 5a ,b, BAX panel). In contrast, no further increase in BAX expression was detected in MCF7 cells by both DNA damage and exogenous p53 (Figure 5c , BAX panel). These results suggest that induction of BAX may be necessary for inducing apoptosis in MCF7 cells.
To further test that p53 and p73 cooperate to activate p53 target genes, we performed a luciferase reporter assay and analysed the regulation of GADD45 promoter by p53 and p73. We found that the activity of GADD45 promoter induced by both p53 and p73 was much higher than the additive by p53 and p73 Figure 4 p73 and DNA damage cooperate to induce apoptosis in MCF7 cells. (a) MCF7 and MCF7E6 cells, that were uninduced (7) or induced (+) to express p73 or p53, were mock-treated (7) or treated (+) with 300 nM camptothecin (CPT) for 3 days. Following Trypan blue dye staining, both live and dead cells were counted and the percentage of dead cells was calculated. (b) Caspase 2 is activated in MCF7 cells when both treated with camptothecin and induced to express p73. The activity of caspase 2 was measured as described in Materials and methods Figure 5 Regulation of cellular target genes by DNA damage, p73, and p53 in MCF7 and MCF7E6 cells. Total RNA was isolated from MCF7 and MCF7E6 cells that were either mock-treated (7) or treated (+) with 300 nM camptothecin (CPT) in the absence (7) or presence (+) of p73 or p53. Northern blots were then prepared using 10 mg total RNA and probed with cDNAs corresponding to the p21, BAX, and GAPDH genes, respectively. The fold of induction was shown below each blot individually ( Figure 6) . Similarly, the promoter of the BAX gene was cooperatively activated by p53 and p73 (data not shown).
Discussion
Many studies have shown that tumor cells with an endogenous wild-type p53 gene are generally more sensitive to ionizing radiation and DNA damaging agents than tumor cells with a dysfunctional p53 gene (Chresta et al., 1996; Lee and Bernstein, 1993; Lowe et al., 1993 Lowe et al., , 1994 O'Connor et al., 1997; Weinstein et al., 1997) . The underlying mechanism for such outcomes may simply be due to the fact that DNA damage can stabilize p53 and convert a`latent' inactive form of p53 to an active one (Giaccia and Kastan, 1998; Prives and Hall, 1999) , leading to apoptosis in tumor cells. In addition, overexpression of exogenous p53 can sensitize many cells that are p53-null, for example, H1299 cells, Saos-2 osteosarcoma cells, and SK-OV-3 ovarian cells, to apoptosis induced by DNA damaging agents (Chen et al., 1996; Gallardo et al., 1996; Wang et al., 1998) . Here we found that p73 cooperates with several DNA damaging agents to induce apoptosis in MCF7, but not in functionally p53-null MCF7E6, cells. Furthermore, p73-mediated apoptosis is inhibited in p53-null H1299 cells when treated with several DNA damaging agents (data not shown). Since p73, unlike p53, is not frequently mutated in human cancer (Chen, 1999; Ichimiya et al., 1999; Kaelin, 1999a) , it has been hoped that p73, or agents that can activate the p73 pathway, may be used as therapeutic agents for p53-defective tumors. Thus, the ®nding here should be taken into consideration if p73 is to be used as a potential therapeutic agent.
Several reports have shown that p73 is stabilized in cells by DNA damage in a c-Abl-dependent manner (Agami et al., 1999; Gong et al., 1999; Yuan et al., 1999) . In MCF7 cells, the c-Abl pathway is functional (Agami et al., 1999) , In addition, we have found that p73 can be stabilized by DNA damage in MCF7E6 cells (Figure 2) , which express the HPV E6 protein. Thus, HPV E6 does not have an adverse eect on the ability of the c-Abl pathway to stabilize p73. These results indicate that the p53, but not the c-Abl, pathway is responsible for the dierential eect of DNA damage on p73-mediated apoptosis between MCF7 and MCF7E6 cells.
Recently, several studies have shown that p73 dierentially regulates some of the p53 target genes (Di Como et al., 1999; Marin et al., 1998; Yu et al., 1999; Zhu et al., 1998a ). Here we found that p73 cooperates with DNA damage (i.e., induction of p53) in MCF7 cells to induce endogenous p21 and BAX, and p53 and p73 cooperate to activate the GADD45 and BAX promoter. Several reports have shown that p73 can bind to the p53 response element in the promoter of several target genes (Di Como et al., 1999; Marin et al., 1998) and a protein complex containing both p53 and p73 has been detected (Di Como et al., 1999; Marin et al., 2000) . Since the promoters for most p53 target genes, for example, the p21 promoter (Resnick-Silverman et al., 1998) , contain two p53 response elements, it is possible that p53 and p73 may separately bind to one of the two response elements. Interaction of p53 and p73 on the promoters would then cooperate to induce their target genes. Such functional interactions have been observed between Sp1 and Smad family proteins on the p21 promoter (Moustakas and Kardassis, 1998; Xiao et al., 1999) . Therefore, future studies using chromatin immunoprecipitation assay are needed to determine whether p53 and p73 form a hetero-complex on, or bind separately to, the promoter of cellular target genes in vivo.
Previous studies have shown that when MCF7 cells are subjected to ionizing radiation or treatment with DNA damaging agents, the endogenous p53 protein is stabilized and activated (Fan et al., 1995; Gupta et al., 1997; O'Connor et al., 1997) , leading to induction of p21 and cell cycle arrest. However, unlike hematopoietic and lymphoid cells that are readily undergoing an apoptotic response to DNA damage, MCF7 cells are less prone to the p53-dependent DNA damage-induced apoptosis. In addition, disruption of p53 function can sensitize MCF7 cells to the G 2 -checkpoint abrogators, taxol and pentoxifylline (Fan et al., 1995) . Similarly, we found that the DNA damaging agent camptothecin stabilized and activated p53 in MCF7 cells but no signi®cant apoptosis was detected by treatment with camptothecin ( Figure 3 ) or doxorubicin in this study. Furthermore, exogenous p53 at a physiologically relevant level, alone or in combination with DNA damaging agents, is unable to elicit an apoptotic response. However, we found that p73 cooperates with DNA damage to induce a strong apoptotic response in MCF7 but not in MCF7E6 cells, suggesting that p53 is necessary for cooperating with other apoptotic stimuli, such as p73, to induce apoptosis in MCF7 cells. Figure 6 p73 and p53 cooperate to activate the promoter of the GADD45 gene. The GADD45-luc reporter vector was cotransfected with pCDNA3 control vector, a pcDNA3 vector that expresses p53 or p73, or a combination of two pcDNA3 vectors that express p53 and p73, respectively. Dual luciferase assay was performed according to the manufacturer's instruction (Promega). The fold increase in relative luciferase activity is a product of the luciferase activity induced by p53, p73, or both divided by that induced by pcDNA3
Materials and methods
Plasmids cDNAs for p73a (Jost et al., 1997) and p53 were cloned separately into a tetracycline-regulated expression vector, 10-3, at its EcoRI and XbaI sites and the resulting plasmids were used to generate cell lines that inducibly express p73 or p53. Both p53 and p73 were tagged at their N-termini with an in¯uenza hemagglutinin (HA) peptide. cDNA for the human papillomavirus E6 gene (Munger et al., 1989) was cloned into pBabe expression vector at its EcoRI and BamHI sites (Morgenstern and Land, 1990) .
Cell lines and DNA damage
The MCF7 cell line, which expresses tet-VP16 for generation of tetracycline inducible cell lines, was purchased from ClonTech (Palo Alto, CA, USA). MCF7 cell lines that express inducible proteins of interest were generated as previously described (Zhu et al., 2000) . Individual clones were screened for inducible expression of p73 protein by Western blot analysis using monoclonal antibody 12CA5 (Boehringer Mannheim Biochemical, Germany). To induce double-strand DNA breaks, cells were treated with camptothecin and doxorubicin (Sigma, St. Louis, MO, USA).
Western blot analysis
Cells were collected from plates in phosphate-buered saline (PBS), resuspended with 16sample buer, and boiled for 5 min. Western blot analysis was performed as described (Chen et al., 1995) , with rabbit anti-HA polyclonal antibody (Sigma, St. Louis, MO, USA), anti-p53 monoclonal antibody Pab240, anity-puri®ed anti-actin polyclonal antibody (Sigma, St. Louis, MO, USA), anti-p73a polyclonal antibody (Ab4) (Oncogene Research Products, Cambridge, MA, USA), or anti-p21 monoclonal antibody (Ab-1) (Oncogene Research Products, Cambridge, MA, USA).
Trypan blue dye exclusion assay
Cells were seeded at 2610 5 per 90-mm plate. After adhering to culture plates, cells were mock-treated or treated with camptothecin or doxorubicin in the presence or absence of tetracycline. Three days after treatment, both¯oating cells in the medium and live cells on the plate were collected and concentrated by centrifugation. After staining with Trypan blue dye (Sigma) for 15 min, both live (unstained) and dead (stained) cells were counted three times in a hemocytometer. The percentage of dead cells was calculated and used as an index for the degree of cell death.
Caspase activity assay
Cells were seeded at 3 ± 5610 5 per 90-mm plate in the presence or absence of tetracycline, which were also mocktreated or treated with 300 nM camptothecin for 3 days. Adherent cells were then rinsed with cold PBS and the caspase activity was assayed using the caspases 2 and 6 colorimetric protease assay reagents according to the manufacturer's instruction (Chemicon International, Inc.). The percentage of increase of relative caspase activity was a product of the activity in cells, which were treated with camptothecin, induced to express p73, or both, divided by that in control cells.
RNA isolation and Northern blot analysis
Total RNA was isolated using Trizol reagents (GIBCO ± BRL). Northern blot analysis was performed as described (Zhu et al., 1998b) . The p21, BAX, and GADPH probes were prepared as previously described (Zhu et al., 1998b) .
Luciferase assay
The GADD45 promoter was cloned upstream of a luciferase reporter gene (Friedlander et al., 1996) . One microgram of the resulting reporter vector was cotransfected into H1299 cells with 0.5 mg of pcDNA3 control vector or a vector expressing p53, p73a, or both. For an internal control, 25 ng of the Renilla luciferase vector pRL-CMV (Promega, Madison, WI, USA) were cotransfected with the above constructs. Dual luciferase assays were performed in triplicate according to the manufacturer's instructions (Promega, Madison, WI, USA).
